ArticleActive
Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A59906
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: September 25, 2025
Updated: December 31, 2025
Policy Summary
This billing/coding guidance requires submitting the appropriate CPT and ICD-10-CM codes, entering the DEX Z-Code adjacent to the CPT code in specified claim fields for Part A and Part B, and reporting one unit of service. Only one molecular test for hereditary transthyretin amyloidosis may be billed per patient, and specific formatting rules apply (e.g., no extra characters on SV101-7).
Coverage Criteria Preview
Key requirements from the full policy
"Only one molecular test for hereditary transthyretin amyloidosis may be billed per patient."
Sign up to see full coverage criteria, indications, and limitations.